Felzartamab ( DrugBank: Felzartamab )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
66	IgA腎症	6
222	一次性ネフローゼ症候群	3

66. IgA腎症

臨床試験数 : 275 / 薬物数 : 258 - (DrugBank : 82) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 140

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05065970 (ClinicalTrials.gov)	August 31, 2021	14/9/2021	Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab(MOR202) in ...	A Double Blind, Randomized, Placebo-Controlled, Multicenter Phase IIa, Clinical Trial to Assess Effi ...	Immunoglobulin A (IgA) Nephropathy	Drug: Felzartamab;Other: Placebo	MorphoSys AG	NULL	Recruiting	18 Years	80 Years	All	48	Phase 2	United States;Australia;Belgium;Bulgaria;Czechia;Georgia;Germany;Japan;Korea, Republic of;Malaysia;P ...
2	EUCTR2020-005054-19-DE (EUCTR)	16/08/2021	01/04/2021	A clinical study to assess efficacy and safety of the human Anti-CD38 Antibody Felzartamabin IgA Nep ...	A Double Blind, Randomized, Placebo-Controlled, Multicenter Phase IIa, Clinical Trial to Assess Effi ...	IgA Nephropathy (IgAN) MedDRA version: 20.0;Level: PT;Classification code 10021263;Term: IgA nephrop ...	Product Name: Felzartamab Product Code: MOR202 INN or Proposed INN: Felzartamab Other descriptive name: ...	MorphoSys AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Phase 2	Serbia;United States;Czechia;Philippines;Taiwan;Spain;Ukraine;United Kingdom;Czech Republic;Canada;M ...
3	EUCTR2020-005054-19-CZ (EUCTR)	28/07/2021	09/03/2021	A clinical study to assess efficacy and safety of the human Anti-CD38 Antibody Felzartamabin IgA Nep ...	A Double Blind, Randomized, Placebo-Controlled, Multicenter Phase IIa, Clinical Trial to Assess Effi ...	IgA Nephropathy (IgAN) MedDRA version: 20.0;Level: PT;Classification code 10021263;Term: IgA nephrop ...	Product Name: Felzartamab Product Code: MOR202 INN or Proposed INN: Felzartamab Other descriptive name: ...	MorphoSys AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Phase 2	Serbia;United States;Czechia;Philippines;Taiwan;Spain;Ukraine;United Kingdom;Czech Republic;Canada;M ...
4	EUCTR2020-005054-19-ES (EUCTR)	08/07/2021	09/07/2021	A clinical study to assess efficacy and safety of the human Anti-CD38 Antibody Felzartamabin IgA Nep ...	A Double Blind, Randomized, Placebo-Controlled, Multicenter Phase IIa, Clinical Trial to Assess Effi ...	IgA Nephropathy (IgAN) MedDRA version: 23.1;Level: PT;Classification code 10084204;Term: Sickle cell ...	Product Name: Felzartamab Product Code: MOR202 INN or Proposed INN: Felzartamab Other descriptive name: ...	MorphoSys AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	44	Phase 2	Serbia;United States;Czechia;Philippines;Taiwan;Spain;Ukraine;United Kingdom;Canada;Malaysia;Belgium ...
5	EUCTR2020-005054-19-BE (EUCTR)	30/06/2021	07/05/2021	A clinical study to assess efficacy and safety of the human Anti-CD38 Antibody Felzartamabin IgA Nep ...	A Double Blind, Randomized, Placebo-Controlled, Multicenter Phase IIa, Clinical Trial to Assess Effi ...	IgA Nephropathy (IgAN) MedDRA version: 20.0;Level: PT;Classification code 10021263;Term: IgA nephrop ...	Product Name: Felzartamab Product Code: MOR202 INN or Proposed INN: Felzartamab Other descriptive name: ...	MorphoSys AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Phase 2	United States;Serbia;Philippines;Czechia;Taiwan;Spain;Ukraine;United Kingdom;Czech Republic;Canada;B ...
6	EUCTR2020-005054-19-BG (EUCTR)	30/06/2021	18/03/2021	A clinical study to assess efficacy and safety of the human Anti-CD38 Antibody Felzartamabin IgA Nep ...	A Double Blind, Randomized, Placebo-Controlled, Multicenter Phase IIa, Clinical Trial to Assess Effi ...	IgA Nephropathy (IgAN) MedDRA version: 20.0;Level: PT;Classification code 10021263;Term: IgA nephrop ...	Product Name: Felzartamab Product Code: MOR202 INN or Proposed INN: Felzartamab Other descriptive name: ...	MorphoSys AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Phase 2	Serbia;United States;Czechia;Philippines;Taiwan;Spain;Ukraine;United Kingdom;Czech Republic;Canada;M ...

First Previous1Next Last

先頭へ

222. 一次性ネフローゼ症候群

臨床試験数 : 310 / 薬物数 : 295 - (DrugBank : 117) / 標的遺伝子数 : 63 - 標的パスウェイ数 : 194

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04893096 (ClinicalTrials.gov)	October 22, 2021	11/5/2021	Rescue Therapy With the Human Anti-CD38 Antibody MOR202 (Felzartamab) in Patients With Membranous Ne ...	Rescue Therapy With the Human Anti-CD38 Antibody MOR202 (Felzartamab) in Patients With Membranous Ne ...	Membranous Nephropathy	Drug: MOR202	Mario Negri Institute for Pharmacological Research	MorphoSys AG	Active, not recruiting	18 Years	N/A	All	10	Phase 2	Italy
2	EUCTR2021-000835-30-IT (EUCTR)	12/10/2021	30/08/2021	MOR202 for refractory MN	RESCUE THERAPY WITH THE HUMAN ANTI-CD38 ANTIBODY MOR202 (FELZARTAMAB) IN PATIENTS WITH MEMBRANOUS NE ...	Membranous Nephropathy who Failed Anti-CD20 Target Therapy. MedDRA version: 21.1;Level: LLT;Classifi ...	Product Name: MOR202 Product Code: [MOR202]	IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	10	Phase 2	Italy
3	EUCTR2019-000780-24-PL (EUCTR)	07/01/2021	14/09/2020	Open Label Clinical Trial to assess Safety and Efficacy of MOR202 in Membranous Nephropathy	A Phase Ib/IIa, Open-Label, Multicenter Clinical Trial to Assess Safety and Efficacy of the Human An ...	Primary (anti-PLA2R antibody positive) Membranous Nephropathy MedDRA version: 21.1;Level: LLT;Classi ...	Product Name: MOR202 Product Code: MOR202 INN or Proposed INN: felzartamab Other descriptive name: MOR0 ...	MorphoSys AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30	Phase 1;Phase 2	France;United States;European Union;Belgium;Spain;Poland;Australia;Netherlands;Italy;Korea, Republic ...

First Previous1Next Last

先頭へ